Novel Staging Schemes for Siewert Type II Esophagogastric Junction Adenocarcinoma: A Real-World Data Cohort Study From SEER Database

Adenocarcinoma of the Esophagogastric Junction Clinical Trial

Official title:
Novel Staging Schemes for Siewert Type II Esophagogastric Junction Adenocarcinoma: A Real-World Data Cohort Study From SEER Database

Status Completed

Clinical Trial Summary

This study have two aims, the first is to explore the optimal cutoff of TLN for Siewert type II AEG using the Surveillance, Epidemiology, and End Results (SEER) database the second is to provide a more accurate staging for Siewert type II AEG patients.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Adenocarcinoma
Adenocarcinoma of the Esophagogastric Junction

Clinical Trial Details

NCT number	NCT05419349
Study type	Observational
Source	Fujian Medical University Union Hospital
Contact
Status	Completed
Phase
Start date	June 1, 2022
Completion date	June 7, 2022

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04062656` - Perioperative Immunotherapy vs. Chemo-immunotherapy in Patients With Advanced GC and AEG	Phase 2
Active, not recruiting	`NCT02509286` - Perioperative Chemotherapy Compared To Neoadjuvant Chemoradiation in Patients With Adenocarcinoma of the Esophagus	Phase 3
Completed	`NCT00849615` - Prospective Study With FLOT in Patients With Locally Advanced, Limited Metastatic or Extensive Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction	Phase 2
Completed	`NCT02287129` - Evaluation for the Individualization of Therapy in Adenocarcinomas of the Gastroesophageal Junction	Phase 2
Recruiting	`NCT03647540` - The Application of Fluorescence Laparoscopy in the Treatment of Adenocarcinoma of the Esophagogastric Junction	N/A
Completed	`NCT00737373` - Oxaliplatin and 5-Fluorouracil With or Without Docetaxel in Elderly Patients (>65 y) With Stomach and Esophagus Cancer	Phase 2